AVP and chronic kidney disease: Following on from animal studies that have implicated a causal role for vasopressin in impaired renal function, there is a growing body of evidence demonstrating an association between copeptin levels (a surrogate marker of vasopressin) and eGFR decline in those with CKD [20, 21].